General Information of the Compound
| Compound ID |
CP0393916
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[3-(1-butyltriazol-4-yl)propoxy]-N-[4-[4-(8-hydroxy-2-oxo-1H-quinolin-5-yl)-1,4-diazepan-1-yl]butyl]-3-methoxybenzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C35H47N7O5
|
||||||||||||||||||
| Molecular Weight |
645.805
|
||||||||||||||||||
| Canonical SMILES |
CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN2CCCN(CC2)c2ccc(O)c3[nH]c(=O)ccc23)nn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C35H47N7O5/c1-3-4-20-42-25-27(38-39-42)9-7-23-47-31-14-10-26(24-32(31)46-2)35(45)36-16-5-6-17-40-18-8-19-41(22-21-40)29-12-13-30(43)34-28(29)11-15-33(44)37-34/h10-15,24-25,43H,3-9,16-23H2,1-2H3,(H,36,45)(H,37,44)
Show/Hide
|
||||||||||||||||||
| InChIKey |
QUFMZNYDEPSZLF-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01195, D(1A) dopamine receptor
Protein ID: PT01169, D(1B) dopamine receptor
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor
Protein ID: PT01161, D(4) dopamine receptor